California Life Sciences Association (CLSA) announced an expansion of its board of directors by adding Wade Ackerman, Partner at Covington & Burling LLP and Richard Ascroft, Vice President, Managed Market and Government Affairs at Takeda Pharmaceuticals.

"As California Life Sciences Association continues to grow and expand our efforts and involvement statewide, we turn to our trusted board of directors to help guide us in the right direction to further enhance California’s innovative life sciences economy," Sara Radcliffe, President & CEO, California Life Sciences Association (CLSA) said. "I’m pleased to welcome Wade Ackerman from Covington & Burling LLP and Richard Ascroft from Takeda Pharmaceuticals USA to our Board. Their insights will help bolster our efforts to drive solution-oriented public policies and advocacy activities that sustain and support life sciences research, investment and innovation in California."